positionForPages[72]={page:72,positions:[{w:"64",p:[0.092525,0.957873,0.109686,0.957873,0.109686,0.938882,0.092525,0.938882,0.008570,0.008591]},{w:"3",p:[0.038824,0.310836,0.060302,0.310836,0.060302,0.263358,0.038824,0.263358,0.021478]},{w:"CHAPTER 3",p:[0.117647,0.067219,0.190423,0.067219,0.190423,0.047140,0.117647,0.047140,0.009172,0.009650,0.008799,0.008861,0.007388,0.007906,0.009359,0.003320,0.008321]},{w:"the tumor samples, which was confirmed by PURPLE, a purity ploidy estimator (",p:[0.117647,0.121273,0.804825,0.121273,0.804825,0.100900,0.117647,0.100900,0.006620,0.011299,0.009039,0.004885,0.006163,0.011413,0.017488,0.010843,0.007807,0.004885,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.004497,0.004885,0.014792,0.011459,0.005547,0.008765,0.011459,0.004885,0.014723,0.009291,0.007670,0.004885,0.008994,0.010843,0.011756,0.005684,0.005684,0.007807,0.017485,0.009108,0.011391,0.004885,0.010843,0.009724,0.004885,0.012167,0.016024,0.013376,0.011664,0.011619,0.012098,0.004497,0.004885,0.009291,0.004885,0.011048,0.011413,0.007807,0.005271,0.006437,0.009724,0.004885,0.011162,0.005182,0.010843,0.005547,0.011322,0.009724,0.004885,0.009039,0.007510,0.006437,0.005615,0.017577,0.008811,0.006209,0.010843,0.007807,0.004885,0.006939]},{w:"Table ",p:[0.804914,0.121273,0.856959,0.121273,0.856959,0.100140,0.804914,0.100140,0.011413,0.009679,0.011528,0.005935,0.009473,0.004018]},{w:"S7",p:[0.117647,0.141852,0.139150,0.141852,0.139150,0.120719,0.117647,0.120719,0.010592,0.010911]},{w:") . In general, based on PURPLE tumor content estimates (",p:[0.139150,0.141852,0.647305,0.141852,0.647305,0.121479,0.139150,0.121479,0.006939,0.018244,0.004497,0.004725,0.006896,0.011756,0.004725,0.009656,0.009039,0.011596,0.009039,0.007898,0.009405,0.004976,0.004497,0.004725,0.011117,0.009291,0.007875,0.009108,0.011391,0.004725,0.010843,0.011756,0.004725,0.012167,0.016024,0.013376,0.011664,0.011619,0.012098,0.004725,0.006163,0.011413,0.017485,0.010843,0.007807,0.004725,0.008994,0.010843,0.011391,0.006209,0.009039,0.011391,0.006437,0.004725,0.009039,0.007510,0.006437,0.005615,0.017577,0.008811,0.006209,0.009039,0.007670,0.004725,0.006939]},{w:"284",p:[0.146089,0.134236,0.164334,0.134236,0.164334,0.122358,0.146089,0.122358,0.006082,0.006082,0.006082]},{w:"Table S7",p:[0.647228,0.141852,0.721369,0.141852,0.721369,0.120719,0.647228,0.120719,0.011413,0.009679,0.011528,0.005935,0.009473,0.004611,0.010592,0.010911]},{w:"), PDOs are en-",p:[0.721370,0.141852,0.852941,0.141852,0.852941,0.121479,0.721370,0.121479,0.006939,0.004497,0.004725,0.011664,0.016504,0.016253,0.007670,0.004725,0.009085,0.007442,0.009039,0.004725,0.009039,0.011731,0.007533]},{w:"riched for tumor cells, whereas tumor samples are heterogeneous, representing a mix of ",p:[0.117647,0.162431,0.857144,0.162431,0.857144,0.142058,0.117647,0.142058,0.007807,0.005547,0.008765,0.011299,0.009108,0.011391,0.004451,0.006026,0.010843,0.007807,0.004451,0.006163,0.011413,0.017485,0.010843,0.007807,0.004451,0.008994,0.008948,0.005387,0.005250,0.007670,0.004497,0.004451,0.014792,0.011299,0.009039,0.007442,0.009291,0.009291,0.007670,0.004451,0.006163,0.011413,0.017485,0.010843,0.007807,0.004451,0.007944,0.009085,0.017280,0.011162,0.005184,0.009039,0.007670,0.004451,0.009085,0.007442,0.009039,0.004451,0.011299,0.009131,0.006209,0.009039,0.007442,0.011048,0.009656,0.009039,0.011596,0.009108,0.010820,0.011413,0.007670,0.004497,0.004451,0.007442,0.009131,0.011071,0.007442,0.009039,0.007873,0.009039,0.011391,0.006437,0.005615,0.011459,0.009861,0.004451,0.009291,0.004451,0.017645,0.005615,0.010089,0.004451,0.010843,0.006209,0.004109]},{w:"tumor cells and normal cells. For tumor samples with tumor content, PDOs retained the ",p:[0.117647,0.183009,0.857123,0.183009,0.857123,0.162636,0.117647,0.162636,0.006163,0.011413,0.017485,0.010843,0.007807,0.003858,0.008994,0.008948,0.005387,0.005250,0.007670,0.003858,0.009085,0.011596,0.011391,0.003858,0.011596,0.010843,0.007807,0.017577,0.009405,0.005250,0.003858,0.008994,0.008948,0.005387,0.005250,0.007670,0.004497,0.003858,0.010683,0.010843,0.007807,0.003858,0.006163,0.011413,0.017485,0.010843,0.007807,0.003858,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.003858,0.014723,0.005273,0.006620,0.011459,0.003858,0.006163,0.011413,0.017485,0.010843,0.007807,0.003858,0.008994,0.010845,0.011391,0.006209,0.009039,0.011391,0.006437,0.004497,0.003858,0.011664,0.016504,0.016253,0.007670,0.003858,0.007442,0.009131,0.006551,0.009085,0.005615,0.011596,0.009108,0.011391,0.003858,0.006620,0.011299,0.009039,0.004109]},{w:"genomic features of the original tumor lesions.",p:[0.117647,0.203588,0.507275,0.203588,0.507275,0.183215,0.117647,0.183215,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.004109,0.006026,0.009291,0.008811,0.006163,0.011413,0.007442,0.009039,0.007670,0.004109,0.010843,0.006209,0.004109,0.006617,0.011302,0.009039,0.004109,0.010843,0.007807,0.005615,0.009861,0.005615,0.011685,0.009405,0.005250,0.004109,0.006163,0.011413,0.017485,0.010843,0.007807,0.004109,0.005182,0.009039,0.007601,0.005547,0.010843,0.011619,0.007670,0.004497]},{w:" ",p:[0.117647,0.243167,0.123993,0.243167,0.123993,0.225227,0.117647,0.225227,0.006346]},{w:"PDO drug response correlates to patients’ clinical response",p:[0.117647,0.260590,0.660203,0.260590,0.660203,0.237430,0.117647,0.237430,0.010733,0.011231,0.011256,0.003984,0.011231,0.011156,0.011156,0.011206,0.003984,0.011231,0.009211,0.010409,0.010733,0.011256,0.011679,0.010409,0.009363,0.003984,0.011007,0.011256,0.011231,0.011231,0.009363,0.008691,0.009463,0.008616,0.009211,0.010409,0.003984,0.008516,0.011256,0.003984,0.010110,0.009463,0.008616,0.004856,0.009363,0.011679,0.008516,0.010409,0.003860,0.003984,0.011007,0.008691,0.004856,0.011679,0.004856,0.010905,0.010558,0.008442,0.003984,0.011231,0.009214,0.010409,0.010733,0.011256,0.011679,0.010409,0.009363]},{w:"Next, we evaluated the potential of PDOs to reflect patients’ drug response to chemother-",p:[0.117647,0.310156,0.852941,0.310156,0.852941,0.289783,0.117647,0.289783,0.015522,0.009108,0.010089,0.006437,0.004497,0.003264,0.014518,0.009039,0.003264,0.009336,0.009838,0.009405,0.004908,0.011596,0.008811,0.006209,0.009108,0.011391,0.003264,0.006617,0.011302,0.009039,0.003264,0.011502,0.010820,0.006211,0.009039,0.011391,0.006437,0.005796,0.009405,0.005250,0.003264,0.010843,0.006209,0.003264,0.011667,0.016501,0.016253,0.007670,0.003264,0.006209,0.011048,0.003264,0.007442,0.009039,0.005638,0.005570,0.009108,0.009108,0.006437,0.003264,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.006277,0.004291,0.003264,0.011391,0.007967,0.011413,0.009861,0.003264,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.003264,0.006209,0.011048,0.003264,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007236,0.007533]},{w:"apy. For this we selected all PDOs that were derived at interval debulking surgery from ",p:[0.117647,0.330735,0.856938,0.330735,0.856938,0.310362,0.117647,0.310362,0.008811,0.011094,0.007989,0.004497,0.005045,0.010683,0.010843,0.007807,0.005045,0.006620,0.011459,0.005615,0.007670,0.005045,0.014518,0.009039,0.005045,0.007875,0.008948,0.005182,0.009108,0.009108,0.006209,0.009108,0.011391,0.005045,0.009405,0.005387,0.005250,0.005045,0.011664,0.016504,0.016253,0.007670,0.005045,0.006620,0.011391,0.008811,0.006437,0.005045,0.014518,0.009039,0.007442,0.009039,0.005045,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.005045,0.008811,0.006437,0.005045,0.005615,0.011391,0.006209,0.009039,0.008400,0.009838,0.009405,0.005250,0.005045,0.011322,0.008902,0.010797,0.011550,0.005387,0.010706,0.005615,0.011459,0.009861,0.005045,0.007512,0.011413,0.007624,0.009656,0.009039,0.008398,0.009724,0.005045,0.006414,0.007442,0.010843,0.017645,0.004109]},{w:"patients with high grade serous (HGS) OC, with known clinical histories (",p:[0.117647,0.351314,0.730564,0.351314,0.730564,0.330941,0.117647,0.330941,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.003538,0.014723,0.005271,0.006620,0.011459,0.003538,0.011459,0.005615,0.009930,0.011459,0.003538,0.009861,0.007898,0.009291,0.011322,0.009039,0.003538,0.007875,0.009039,0.007442,0.010820,0.011413,0.007670,0.003538,0.006939,0.016412,0.015682,0.010112,0.006939,0.003538,0.016778,0.014678,0.004497,0.003538,0.014723,0.005273,0.006620,0.011459,0.003538,0.010703,0.011598,0.010863,0.014723,0.011756,0.003538,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.003538,0.011459,0.005615,0.007510,0.006209,0.010843,0.007807,0.005547,0.009039,0.007670,0.003538,0.006939]},{w:"Table S1",p:[0.730557,0.351314,0.803545,0.351314,0.803545,0.330181,0.730557,0.330181,0.011413,0.009679,0.011528,0.005935,0.009473,0.003458,0.010592,0.010911]},{w:" (clin-",p:[0.803545,0.351314,0.852941,0.351314,0.852941,0.330941,0.803545,0.330941,0.003538,0.006939,0.008765,0.005250,0.005615,0.011755,0.007533]},{w:"ical comparison) and  ). Seven PDOs (derived from five patients) were exposed to car-",p:[0.117647,0.371892,0.852941,0.371892,0.852941,0.351520,0.117647,0.351520,0.005547,0.009108,0.009405,0.005250,0.004086,0.008994,0.010843,0.017280,0.011368,0.009085,0.007807,0.005615,0.007875,0.010843,0.011756,0.006939,0.004086,0.009085,0.011596,0.011391,0.004109,0.021474,0.006939,0.004497,0.004086,0.010592,0.009336,0.009633,0.009039,0.011756,0.004086,0.011664,0.016504,0.016253,0.007670,0.004086,0.006939,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.004086,0.006414,0.007442,0.010843,0.017645,0.004086,0.005684,0.005615,0.009633,0.009039,0.004086,0.011368,0.008809,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.006939,0.004086,0.014518,0.009039,0.007442,0.009039,0.004086,0.009108,0.010089,0.011505,0.010957,0.007875,0.009106,0.011391,0.004086,0.006209,0.011048,0.004086,0.009108,0.009085,0.007221,0.007533]},{w:"S2",p:[0.299685,0.371892,0.321188,0.371892,0.321188,0.350760,0.299685,0.350760,0.010592,0.010911]},{w:"boplatin and paclitaxel combination treatment ",p:[0.117647,0.392471,0.517378,0.392471,0.517378,0.372098,0.117647,0.372098,0.011254,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.005216,0.009085,0.011596,0.011391,0.005216,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.005216,0.008994,0.010843,0.017394,0.010820,0.005615,0.011687,0.008811,0.006437,0.005547,0.010843,0.011756,0.005227,0.006437,0.007442,0.009288,0.008813,0.006437,0.017485,0.009039,0.011391,0.006437,0.004109]},{w:"in vitro",p:[0.518475,0.392940,0.585061,0.392940,0.585061,0.370918,0.518475,0.370918,0.005935,0.012144,0.006643,0.010500,0.005912,0.006802,0.007921,0.010729]},{w:" and we could directly compare ",p:[0.585055,0.392471,0.857059,0.392471,0.857059,0.372098,0.585055,0.372098,0.005216,0.009085,0.011596,0.011391,0.005227,0.014518,0.009039,0.005216,0.008994,0.010820,0.011550,0.005182,0.011391,0.005216,0.011391,0.005615,0.007442,0.009108,0.009108,0.006620,0.005182,0.009724,0.005216,0.008994,0.010843,0.017280,0.011368,0.009085,0.007442,0.009039,0.004109]},{w:"their response to the patient’s clinical response. Related samples HGS-3.1 and HGS-3.2 ",p:[0.117647,0.413050,0.857098,0.413050,0.857098,0.392677,0.117647,0.392677,0.006620,0.011299,0.009039,0.005615,0.007807,0.005033,0.007442,0.009039,0.007512,0.011502,0.010843,0.011619,0.007875,0.009039,0.005045,0.006209,0.011048,0.005033,0.006620,0.011299,0.009039,0.005045,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.005456,0.001735,0.007670,0.005033,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.005033,0.007442,0.009039,0.007512,0.011502,0.010843,0.011621,0.007873,0.008743,0.004497,0.005045,0.013696,0.008948,0.005433,0.008811,0.006209,0.009108,0.011391,0.005033,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.005045,0.016412,0.015682,0.010112,0.007533,0.010432,0.004497,0.010432,0.005045,0.009085,0.011596,0.011391,0.005033,0.016412,0.015682,0.010112,0.007533,0.010432,0.004497,0.010432,0.004109]},{w:"were most responsive to carboplatin and paclitaxel combination treatment (AUC=0.37 ",p:[0.117647,0.433629,0.857029,0.433629,0.857029,0.413256,0.117647,0.413256,0.014518,0.009039,0.007442,0.009039,0.005159,0.017485,0.010957,0.007510,0.006437,0.005159,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.005159,0.006211,0.011048,0.005159,0.009106,0.009087,0.007715,0.011251,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.005159,0.009085,0.011596,0.011391,0.005159,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.005159,0.008994,0.010843,0.017394,0.010820,0.005615,0.011687,0.008811,0.006437,0.005547,0.010843,0.011756,0.005159,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.005159,0.006939,0.013513,0.016024,0.014678,0.011779,0.010432,0.004497,0.010432,0.010432,0.004109]},{w:"and 0.29), while HGS-24 was the least responsive (AUC=0.88) (",p:[0.117647,0.454207,0.662577,0.454207,0.662577,0.433834,0.117647,0.433834,0.009085,0.011596,0.011391,0.005570,0.010432,0.004497,0.010432,0.010432,0.006939,0.004497,0.005558,0.014789,0.011459,0.005752,0.005182,0.009039,0.005570,0.016412,0.015682,0.010112,0.007533,0.010432,0.010432,0.005558,0.014723,0.009291,0.007670,0.005558,0.006620,0.011299,0.009039,0.005570,0.005182,0.009291,0.009291,0.007510,0.006437,0.005570,0.007442,0.009039,0.007510,0.011502,0.010845,0.011619,0.007601,0.005547,0.009633,0.009039,0.005558,0.006939,0.013513,0.016024,0.014678,0.011779,0.010432,0.004497,0.010432,0.010432,0.006939,0.005558,0.006939]},{w:"Figure 1",p:[0.662539,0.454207,0.737069,0.454207,0.737069,0.433074,0.662539,0.433074,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.005433,0.010911]},{w:"). These PDO ",p:[0.737071,0.454207,0.857060,0.454207,0.857060,0.433834,0.737071,0.433834,0.006939,0.004497,0.005558,0.011470,0.011311,0.009039,0.007875,0.009039,0.005570,0.011664,0.016504,0.016412,0.004109]},{w:"drug responses showed a statistically significant correlation (p<0.01) with clinical re-",p:[0.117647,0.474786,0.852941,0.474786,0.852941,0.454413,0.117647,0.454413,0.011391,0.007967,0.011413,0.009861,0.006894,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.007670,0.006894,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.006894,0.009291,0.006894,0.007512,0.006551,0.008809,0.006437,0.005615,0.007510,0.006437,0.005547,0.009108,0.009405,0.005387,0.005182,0.009724,0.006894,0.007601,0.005615,0.009861,0.011756,0.005615,0.005684,0.005615,0.009108,0.009085,0.011391,0.006437,0.006894,0.008994,0.010843,0.007807,0.007442,0.008948,0.005433,0.008811,0.006437,0.005547,0.010843,0.011756,0.006894,0.006939,0.011276,0.011550,0.010432,0.004497,0.010432,0.010432,0.006939,0.006894,0.014723,0.005273,0.006620,0.011459,0.006894,0.008765,0.005250,0.005615,0.011756,0.005547,0.009106,0.009405,0.005250,0.006894,0.007442,0.009062,0.007533]},{w:"sponse as measured by histopathological (chemotherapy response score (CRS)), bio-",p:[0.117647,0.495365,0.852941,0.495365,0.852941,0.474992,0.117647,0.474992,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.007122,0.009291,0.007670,0.007122,0.017485,0.009291,0.009291,0.007510,0.011413,0.007442,0.009108,0.011391,0.007122,0.010840,0.009724,0.007122,0.011459,0.005615,0.007510,0.006209,0.010820,0.011368,0.008811,0.006620,0.011299,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.007122,0.006939,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011094,0.009724,0.007122,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.007122,0.007875,0.008994,0.010843,0.007442,0.009039,0.007122,0.006939,0.014678,0.013376,0.010112,0.006939,0.006939,0.004497,0.007122,0.010820,0.005547,0.011025,0.007533]},{w:"chemical (normalization of serum biomarker CA-125) and radiological (RECIST) re-",p:[0.117647,0.515943,0.852941,0.515943,0.852941,0.495570,0.117647,0.495570,0.008765,0.011299,0.009039,0.017645,0.005547,0.009108,0.009405,0.005250,0.006378,0.006939,0.011596,0.010843,0.007807,0.017577,0.009405,0.005250,0.005615,0.008834,0.008811,0.006437,0.005547,0.010843,0.011756,0.006378,0.010845,0.006209,0.006378,0.007875,0.009039,0.007967,0.011413,0.017645,0.006378,0.010820,0.005547,0.010843,0.017577,0.009085,0.007601,0.010272,0.009039,0.007807,0.006380,0.014678,0.013605,0.007533,0.010432,0.010432,0.010432,0.006939,0.006378,0.009085,0.011596,0.011391,0.006378,0.007898,0.009291,0.011391,0.005547,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.006378,0.006939,0.013376,0.012098,0.014678,0.007259,0.009861,0.013240,0.006939,0.006378,0.007442,0.009042,0.007533]},{w:"sponses (",p:[0.117647,0.536522,0.194276,0.536522,0.194276,0.516149,0.117647,0.516149,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.007670,0.003629,0.006939]},{w:"Figure 1; Figure S1D-H",p:[0.194275,0.536522,0.399906,0.536522,0.399906,0.515389,0.194275,0.515389,0.011596,0.006209,0.010751,0.011893,0.008263,0.009473,0.003547,0.010911,0.005433,0.003547,0.011598,0.006209,0.010749,0.011893,0.008263,0.009473,0.003550,0.010592,0.010911,0.016527,0.007213,0.017029]},{w:"). The derivation of organoids upon interval debulking ",p:[0.399904,0.536522,0.857058,0.536522,0.857058,0.516149,0.399904,0.516149,0.006939,0.004497,0.003629,0.011470,0.011311,0.009039,0.003629,0.011322,0.009039,0.007807,0.005547,0.009838,0.008811,0.006437,0.005547,0.010843,0.011756,0.003629,0.010843,0.006209,0.003629,0.010843,0.007626,0.009861,0.009083,0.011598,0.010843,0.005547,0.011391,0.007670,0.003629,0.011071,0.011505,0.010843,0.011756,0.003629,0.005615,0.011391,0.006209,0.009039,0.008400,0.009838,0.009405,0.005250,0.003629,0.011322,0.008902,0.010797,0.011550,0.005387,0.010706,0.005615,0.011459,0.009861,0.004109]},{w:"was restricted to CRS1 and CRS2 scored samples and therefore a high-risk subgroup of ",p:[0.117647,0.557101,0.857052,0.557101,0.857052,0.536728,0.117647,0.536728,0.014723,0.009291,0.007670,0.004725,0.007442,0.009039,0.007510,0.006437,0.007807,0.005547,0.009108,0.006209,0.009108,0.011391,0.004725,0.006209,0.011048,0.004725,0.014678,0.013376,0.010112,0.010432,0.004725,0.009085,0.011596,0.011391,0.004725,0.014678,0.013376,0.010112,0.010432,0.004725,0.007875,0.008994,0.010843,0.007442,0.009108,0.011391,0.004725,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.004725,0.009085,0.011596,0.011391,0.004725,0.006620,0.011299,0.009039,0.007442,0.009039,0.006026,0.010843,0.007442,0.009039,0.004725,0.009291,0.004725,0.011459,0.005615,0.009930,0.011459,0.007533,0.007807,0.005615,0.007556,0.010523,0.004725,0.007510,0.011345,0.011025,0.009861,0.007442,0.010820,0.011071,0.011276,0.004725,0.010843,0.006209,0.004109]},{w:"patients, as CRS3 scored samples will not have macroscopic tumor lesions from which ",p:[0.117647,0.577679,0.857132,0.577679,0.857132,0.557307,0.117647,0.557307,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004497,0.005296,0.009291,0.007670,0.005284,0.014678,0.013376,0.010112,0.010432,0.005296,0.007875,0.008994,0.010843,0.007442,0.009108,0.011391,0.005284,0.007944,0.009085,0.017280,0.011162,0.005184,0.009039,0.007670,0.005284,0.014723,0.005752,0.005387,0.005250,0.005296,0.011596,0.010820,0.006437,0.005296,0.011391,0.008925,0.009633,0.009039,0.005296,0.017577,0.009291,0.008994,0.007442,0.010957,0.007875,0.008994,0.010820,0.011069,0.005547,0.008994,0.005296,0.006163,0.011413,0.017485,0.010843,0.007807,0.005296,0.005182,0.009039,0.007601,0.005547,0.010843,0.011619,0.007670,0.005296,0.006414,0.007442,0.010843,0.017645,0.005296,0.014792,0.011459,0.005547,0.008765,0.011459,0.004109]},{w:"the pathologist can provide tissue for organoid derivation. PDOs derived from tumor lo-",p:[0.117647,0.598258,0.852941,0.598258,0.852941,0.577885,0.117647,0.577885,0.006620,0.011299,0.009039,0.003538,0.011368,0.008811,0.006620,0.011299,0.010934,0.005182,0.011048,0.009861,0.005615,0.007510,0.006437,0.003538,0.009108,0.009085,0.011756,0.003538,0.011071,0.007442,0.010866,0.009838,0.005547,0.011322,0.009039,0.003538,0.006437,0.005615,0.007533,0.007510,0.011345,0.009039,0.003538,0.006026,0.010843,0.007807,0.003538,0.010843,0.007624,0.009861,0.009085,0.011596,0.010843,0.005547,0.011391,0.003538,0.011320,0.009039,0.007807,0.005547,0.009838,0.008811,0.006437,0.005547,0.010843,0.011756,0.004497,0.003538,0.011664,0.016504,0.016253,0.007670,0.003538,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.003538,0.006414,0.007442,0.010843,0.017645,0.003538,0.006163,0.011413,0.017485,0.010843,0.007807,0.003538,0.005182,0.011025,0.007533]},{w:"cations with no or minimal histopathological response (CRS=1) were less responsive to ",p:[0.117647,0.618837,0.857109,0.618837,0.857109,0.598464,0.117647,0.598464,0.009108,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.004679,0.014723,0.005271,0.006620,0.011459,0.004679,0.011596,0.011048,0.004668,0.010845,0.007807,0.004668,0.017645,0.005615,0.011756,0.005615,0.017577,0.009405,0.005250,0.004668,0.011459,0.005615,0.007510,0.006209,0.010820,0.011368,0.008811,0.006620,0.011299,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.004668,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004679,0.006939,0.014678,0.013376,0.010112,0.011779,0.010432,0.006939,0.004679,0.014518,0.009039,0.007442,0.009039,0.004668,0.005182,0.009039,0.007533,0.007670,0.004679,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.004679,0.006209,0.011048,0.004109]},{w:"carboplatin and paclitaxel combination treatment compared to PDOs derived from tu-",p:[0.117647,0.639416,0.852941,0.639416,0.852941,0.619043,0.117647,0.619043,0.009108,0.009085,0.007715,0.011254,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.004839,0.009085,0.011596,0.011391,0.004839,0.011368,0.009291,0.008765,0.005250,0.005271,0.006551,0.009291,0.009884,0.008948,0.005250,0.004839,0.008994,0.010843,0.017394,0.010820,0.005615,0.011687,0.008811,0.006437,0.005547,0.010843,0.011756,0.004839,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004839,0.008994,0.010840,0.017282,0.011365,0.009087,0.007442,0.009106,0.011391,0.004839,0.006209,0.011048,0.004839,0.011662,0.016504,0.016253,0.007670,0.004839,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.004839,0.006414,0.007442,0.010843,0.017645,0.004839,0.006163,0.011509,0.007533]},{w:"mor locations with appreciable pathological response (CRS=2) (p=5.821e-05, Wilcoxon ",p:[0.117647,0.659994,0.857096,0.659994,0.857096,0.639621,0.117647,0.639621,0.017485,0.010843,0.007807,0.004154,0.005182,0.011276,0.009108,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.004154,0.014723,0.005273,0.006620,0.011459,0.004154,0.008811,0.011048,0.011071,0.007442,0.009108,0.008994,0.005798,0.009108,0.010911,0.005182,0.009039,0.004154,0.011365,0.008811,0.006620,0.011299,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.004154,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004154,0.006939,0.014678,0.013376,0.010112,0.011779,0.010432,0.006939,0.004154,0.006939,0.011276,0.011779,0.010432,0.004497,0.010432,0.010432,0.010432,0.009039,0.007533,0.010432,0.010432,0.004497,0.004154,0.019951,0.005752,0.005182,0.008994,0.010820,0.009884,0.010843,0.011756,0.004109]},{w:"signed-rank test) . Biochemically, clinical drug response is measured according to the ",p:[0.117647,0.680573,0.857077,0.680573,0.857077,0.660200,0.117647,0.660200,0.007601,0.005615,0.009861,0.011596,0.009108,0.011391,0.007533,0.007898,0.009085,0.011870,0.010523,0.005068,0.006209,0.009039,0.007510,0.006437,0.006939,0.018241,0.004497,0.005068,0.012486,0.005547,0.011276,0.008765,0.011299,0.009039,0.017645,0.005547,0.009106,0.009405,0.005387,0.005182,0.007989,0.004497,0.005068,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.005068,0.011391,0.007967,0.011413,0.009861,0.005068,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005068,0.005615,0.007670,0.005068,0.017485,0.009291,0.009291,0.007510,0.011413,0.007442,0.009108,0.011391,0.005068,0.009291,0.008994,0.008994,0.010843,0.007442,0.011391,0.005615,0.011459,0.009861,0.005068,0.006211,0.011048,0.005068,0.006620,0.011299,0.009039,0.004109]},{w:"285",p:[0.260927,0.672957,0.279172,0.672957,0.279172,0.661079,0.260927,0.661079,0.006082,0.006082,0.006082]},{w:"response criteria and timing of normalization of CA-125",p:[0.117647,0.701152,0.598445,0.701152,0.598445,0.680779,0.117647,0.680779,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005068,0.008994,0.007807,0.005273,0.006209,0.009039,0.007807,0.005798,0.009291,0.005068,0.009085,0.011596,0.011391,0.005068,0.006437,0.005615,0.017645,0.005615,0.011459,0.009861,0.005068,0.010843,0.006209,0.005068,0.011596,0.010843,0.007807,0.017577,0.009405,0.005250,0.005615,0.008834,0.008811,0.006437,0.005547,0.010843,0.011756,0.005068,0.010843,0.006209,0.005068,0.014678,0.013602,0.007533,0.010432,0.010432,0.010432]},{w:"286,287",p:[0.598512,0.693536,0.637625,0.693536,0.637625,0.681658,0.598512,0.681658,0.006082,0.006082,0.006082,0.002622,0.006082,0.006082,0.006082]},{w:". Even though all patients ",p:[0.637623,0.701152,0.857009,0.701152,0.857009,0.680779,0.637623,0.680779,0.004497,0.005068,0.011801,0.009633,0.009039,0.011756,0.005068,0.006620,0.011299,0.010820,0.011413,0.009930,0.011459,0.005068,0.009405,0.005387,0.005250,0.005068,0.011365,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004109]},{w:"exhibited CA-125 response during primary treatment, PDOs derived from patients who ",p:[0.117647,0.721730,0.856947,0.721730,0.856947,0.701357,0.117647,0.701357,0.009108,0.010089,0.011459,0.005547,0.010820,0.005271,0.006211,0.009106,0.011391,0.003835,0.014678,0.013602,0.007533,0.010432,0.010432,0.010432,0.003835,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.003835,0.011048,0.011413,0.007807,0.005615,0.011459,0.009861,0.003835,0.011071,0.007807,0.005615,0.017577,0.009085,0.008398,0.009724,0.003835,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004497,0.003835,0.011664,0.016501,0.016253,0.007670,0.003835,0.011320,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.003835,0.006412,0.007442,0.010843,0.017645,0.003835,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.003835,0.014792,0.011299,0.011048,0.004109]},{w:"did not reach CA-125 normalization during primary treatment were less responsive to ",p:[0.117647,0.742309,0.857121,0.742309,0.857121,0.721936,0.117647,0.721936,0.011391,0.005547,0.011391,0.005341,0.011596,0.010820,0.006437,0.005341,0.007444,0.009288,0.009291,0.008765,0.011459,0.005341,0.014678,0.013602,0.007533,0.010432,0.010432,0.010432,0.005341,0.011596,0.010843,0.007807,0.017577,0.009405,0.005250,0.005615,0.008834,0.008811,0.006437,0.005547,0.010843,0.011756,0.005341,0.011048,0.011413,0.007807,0.005615,0.011459,0.009861,0.005341,0.011071,0.007807,0.005615,0.017577,0.009085,0.008400,0.009724,0.005341,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.005341,0.014518,0.009039,0.007442,0.009039,0.005341,0.005182,0.009039,0.007533,0.007670,0.005341,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009635,0.009039,0.005341,0.006209,0.011048,0.004109]},{w:"the chemotherapeutics compared to PDOs from the patient in whom CA-125 levels ",p:[0.117647,0.762888,0.857007,0.762888,0.857007,0.742515,0.117647,0.742515,0.006620,0.011299,0.009039,0.007145,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011505,0.009131,0.011071,0.006437,0.005547,0.008994,0.007670,0.007145,0.008994,0.010843,0.017280,0.011368,0.009085,0.007442,0.009108,0.011391,0.007145,0.006209,0.011048,0.007145,0.011664,0.016504,0.016253,0.007670,0.007145,0.006414,0.007442,0.010843,0.017645,0.007145,0.006620,0.011299,0.009039,0.007145,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007145,0.005615,0.011756,0.007145,0.014792,0.011299,0.010843,0.017645,0.007145,0.014678,0.013605,0.007533,0.010432,0.010432,0.010432,0.007145,0.005182,0.009336,0.009633,0.008948,0.005250,0.007670,0.004109]},{w:"normalized (<35kU/L, p=0.0004). Radiological response was assessed according to the ",p:[0.117647,0.783466,0.857055,0.783466,0.857055,0.763094,0.117647,0.763094,0.011596,0.010843,0.007807,0.017577,0.009405,0.005250,0.005615,0.008834,0.009108,0.011391,0.005205,0.006939,0.011550,0.010432,0.010432,0.010523,0.016024,0.007099,0.011619,0.004497,0.005205,0.011276,0.011779,0.010432,0.004497,0.010432,0.010432,0.010432,0.010432,0.006939,0.004497,0.005205,0.013902,0.009291,0.011391,0.005547,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.005205,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005205,0.014723,0.009291,0.007670,0.005205,0.009291,0.007533,0.007875,0.009039,0.007533,0.007875,0.009108,0.011391,0.005205,0.009291,0.008994,0.008994,0.010843,0.007442,0.011391,0.005615,0.011459,0.009861,0.005205,0.006209,0.011048,0.005205,0.006620,0.011302,0.009039,0.004109]},{w:"RECIST criteria (version 1.1) , comparing imaging data at initiation of chemotherapy ",p:[0.117647,0.804045,0.857036,0.804045,0.857036,0.783672,0.117647,0.783672,0.013376,0.012098,0.014678,0.007259,0.009861,0.013354,0.005022,0.008994,0.007807,0.005271,0.006211,0.009039,0.007807,0.005796,0.009291,0.005022,0.006939,0.009633,0.009039,0.007624,0.007601,0.005547,0.010843,0.011756,0.005022,0.010432,0.004497,0.010432,0.006939,0.018250,0.004497,0.005022,0.008994,0.010843,0.017280,0.011368,0.009085,0.007807,0.005615,0.011459,0.009861,0.005022,0.005615,0.017577,0.009197,0.009861,0.005615,0.011459,0.009861,0.005022,0.011573,0.008811,0.006551,0.009291,0.005022,0.008811,0.006437,0.005022,0.005615,0.011756,0.005273,0.006437,0.005796,0.008813,0.006437,0.005545,0.010845,0.011756,0.005022,0.010843,0.006209,0.005022,0.008765,0.011299,0.009039,0.017485,0.010822,0.006617,0.011302,0.009039,0.007896,0.008811,0.011094,0.009724,0.004109]},{w:"287",p:[0.364842,0.796429,0.383087,0.796429,0.383087,0.784552,0.364842,0.784552,0.006082,0.006082,0.006082]},{w:"to imaging data prior to interval debulking based on CT-scanning. PDOs derived from ",p:[0.117647,0.824624,0.856979,0.824624,0.856979,0.804251,0.117647,0.804251,0.006209,0.011048,0.004748,0.005615,0.017577,0.009197,0.009861,0.005615,0.011459,0.009861,0.004748,0.011573,0.008811,0.006551,0.009291,0.004748,0.011071,0.007807,0.005547,0.010843,0.007807,0.004748,0.006209,0.011048,0.004748,0.005615,0.011391,0.006209,0.009039,0.008398,0.009838,0.009405,0.005250,0.004748,0.011322,0.008902,0.010797,0.011550,0.005387,0.010706,0.005615,0.011459,0.009861,0.004748,0.011117,0.009291,0.007875,0.009108,0.011391,0.004748,0.010843,0.011756,0.004748,0.014678,0.011801,0.007533,0.007875,0.009108,0.009085,0.011756,0.011756,0.005615,0.011461,0.009679,0.004497,0.004748,0.011664,0.016504,0.016253,0.007670,0.004748,0.011322,0.009039,0.007807,0.005545,0.009635,0.009106,0.011391,0.004748,0.006414,0.007442,0.010843,0.017645,0.004109]},{w:"patients with RECIST stable disease were less responsive to carboplatin and paclitaxel ",p:[0.117647,0.845203,0.857009,0.845203,0.857009,0.824830,0.117647,0.824830,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.005958,0.014723,0.005273,0.006620,0.011459,0.005958,0.013376,0.012098,0.014678,0.007259,0.009861,0.013354,0.005958,0.007510,0.006551,0.009108,0.010911,0.005182,0.009039,0.005958,0.011391,0.005615,0.007875,0.009291,0.009291,0.007875,0.009039,0.005958,0.014518,0.009039,0.007442,0.009039,0.005958,0.005182,0.009039,0.007535,0.007670,0.005958,0.007442,0.009039,0.007512,0.011502,0.010843,0.011619,0.007604,0.005545,0.009635,0.009039,0.005958,0.006209,0.011048,0.005958,0.009106,0.009087,0.007713,0.011254,0.010820,0.011162,0.005433,0.008811,0.006437,0.005615,0.011756,0.005958,0.009085,0.011596,0.011391,0.005958,0.011368,0.009291,0.008765,0.005250,0.005273,0.006551,0.009291,0.009884,0.008948,0.005250,0.004109]},{w:"combination treatment compared to PDOs from patients with RECIST partial response ",p:[0.117647,0.865781,0.857141,0.865781,0.857141,0.845408,0.117647,0.845408,0.008994,0.010843,0.017394,0.010820,0.005615,0.011687,0.008811,0.006437,0.005547,0.010843,0.011756,0.004109,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004109,0.008994,0.010843,0.017280,0.011368,0.009085,0.007442,0.009108,0.011391,0.004109,0.006209,0.011048,0.004109,0.011664,0.016504,0.016253,0.007670,0.004109,0.006414,0.007442,0.010843,0.017645,0.004109,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004109,0.014723,0.005273,0.006620,0.011459,0.004109,0.013376,0.012098,0.014678,0.007259,0.009861,0.013354,0.004109,0.011365,0.009085,0.007967,0.006437,0.005798,0.009405,0.005250,0.004109,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004109]},{w:"(p=0.0092). To compare long-term clinical response to PDO response, recurrence and ",p:[0.117647,0.886360,0.857077,0.886360,0.857077,0.865987,0.117647,0.865987,0.006939,0.011276,0.011779,0.010432,0.004497,0.010432,0.010432,0.010432,0.010432,0.006939,0.004497,0.005615,0.010866,0.011048,0.005615,0.008994,0.010843,0.017280,0.011368,0.009085,0.007442,0.009039,0.005615,0.005182,0.010843,0.011459,0.009861,0.007533,0.006209,0.009039,0.007807,0.017645,0.005615,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.005615,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005615,0.006209,0.011048,0.005615,0.011664,0.016504,0.016412,0.005615,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.008743,0.004497,0.005615,0.007442,0.009108,0.009108,0.011413,0.007807,0.007442,0.009039,0.011596,0.008994,0.009039,0.005615,0.009085,0.011598,0.011391,0.004109]},{w:"survival were assessed. All patients experienced recurrent disease within four to 14 ",p:[0.117647,0.906939,0.857070,0.906939,0.857070,0.886566,0.117647,0.886566,0.007510,0.011413,0.008400,0.009838,0.005547,0.009838,0.009405,0.005250,0.008126,0.014518,0.009039,0.007442,0.009039,0.008126,0.009291,0.007533,0.007875,0.009039,0.007533,0.007875,0.009108,0.011117,0.004497,0.008126,0.015066,0.005387,0.005250,0.008126,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.008126,0.009108,0.010089,0.011502,0.009039,0.007807,0.005547,0.009039,0.011596,0.008994,0.009108,0.011391,0.008126,0.007442,0.009108,0.009108,0.011413,0.007807,0.007442,0.009039,0.011391,0.006437,0.008126,0.011391,0.005615,0.007873,0.009291,0.009291,0.007875,0.009039,0.008126,0.014723,0.005273,0.006620,0.011459,0.005615,0.011756,0.008126,0.006026,0.010820,0.011413,0.007807,0.008126,0.006209,0.011048,0.008126,0.010432,0.010432,0.004109]}]};